Kardiologiia 2011-01-01

[Nephroprotection diabetes mellitus type 2: lessons from the ADVANCE trial].

S V Nedogoda

Index: Kardiologiia 51(12) , 57-9, (2011)

Full Text: HTML

Abstract

Based on the results of the ADVANCE study, the article considers the issues of medication nephroprotection in patients with type 2 diabetes mellitus, including patients with uncontrolled arterial hypertension. Potentials for use of fixed combination of perindopril + indapmide, which provides therapeutic effect at all stages of renal continuum, are discussed. It is established that improved control of blood pressure by combination of perindopril + indapmide leads to a significant decrease in mortality in DM 2 patients.